Cardioversion of atrial fibrillation: From guidelines to contemporary clinical practice

International Journal of Clinical Practice

Volumn 61, Issue 5, 2007, Pages 714-716

  Lip, Gregory Y H ^a  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT;

AGING; ANTICOAGULATION; CARDIOVERSION; CLINICAL PRACTICE; COMORBIDITY; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; DISEASE DURATION; EDITORIAL; HEART ATRIUM ENLARGEMENT; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART DISEASE; HIGH RISK PATIENT; HUMAN; HYPERTENSION; MITRAL VALVE STENOSIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; RELAPSE; SINUS RHYTHM; THROMBOEMBOLISM; THROMBOSIS; TREATMENT CONTRAINDICATION; TREATMENT INDICATION;

ATRIAL FIBRILLATION; ELECTRIC COUNTERSHOCK; HUMANS; PRACTICE GUIDELINES; REFERRAL AND CONSULTATION;

EID: 34247100606     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2007.01306.x     Document Type: Editorial

References (10)

1. Miyasaka Y, Barnes ME, Gersh BJ et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation 2006; 114: 119-25.
2. Lloyd-Jones DM, Wang TJ, Leip EP et al. Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation 2004; 110: 1042-6.
3. Heeringa J, van der Kuip DA, Hofman A et al. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. Eur Heart J 2006; 27: 949-53.
4. Stewart S, Murphy N, Walker A, McGuire A, McMurray JJ. Cost of an emerging epidemic - an economic analysis of atrial fibrillation in the UK. Heart 2004; 90: 286-92.
5. Fuster V, Ryden LE, Cannom DS et al. American College of Cardiology/ American Heart Association Task Force on Practice Guidelines; European Society of Cardiology Committee for Practice Guidelines; European Heart Rhythm Association; Heart Rhythm Society. ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006; 114: e257-354.
6. National Collaborating Centre for Chronic Conditions. Atrial Fibrillation: National Clinical Guideline for Management in Primary and Secondary Care. London: Royal College of Physicians, 2006.
7. Lip GY, Rudolf M. The new NICE guideline on atrial fibrillation management. Heart 2007; 93: 23 (Epub 4 September 2006).
8. Sulke N, Sulke N, Sayers F, Lip GY. Guideline Development Group for the NICE clinical guideline for the management of atrial fibrillation. Rhythm control and cardioversion. Heart 2007; 93: 29-34 (Epub 8 September 2006).
9. Boriani G, Diemberger I, Biffi M et al. Electrical cardioversion for persistent atrial fibrillation or atrial flutter in clinical practice: predictors of long-term outcome. Int J Clin Pract 2007; 61: 748-56.
10. Lip GY, Tello-Montoliu A. Management of atrial fibrillation. Heart 2006; 92: 1177-82.